Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03743493 · ClinicalTrials.gov registry record

PCORnet Opioid Surveillance Study

A clinical trial of Opioid Use and Opioid Abuse, sponsored by Louisiana Public Health Institute.

Completed
Registry status
15,438,284
Enrollment target
20
Study locations

NCT03743493: Completed study of Opioid Use and Opioid Abuse, sponsored by Louisiana Public Health Institute.

NCT03743493 is a study of Opioid Use and Opioid Abuse that has completed, run by Louisiana Public Health Institute. The registered enrollment target is 15,438,284 participants, above the 1,229-participant average among 105 other Opioid Use trials with a reported enrollment target (1256066% higher). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03743493, a study of Opioid Use and Opioid Abuse, has completed, sponsored by Louisiana Public Health Institute.

COMPLETED
Registry status
15,438,284 participants
Enrollment target
20
Study locations

Study Summary

The overarching objective of this project is to demonstrate and assess the feasibility of using the Patient Centered Outcomes Research Network (PCORnet) Common Data Model for opioid surveillance to complement existing and support future initiatives. This project will characterize risk factors, processes, and outcomes related to opioid use, misuse, and abuse. It will quantify the utility of data stored in the PCORnet Common Data Model format stewarded by healthcare organizations participating in PCORnet.

Primary Outcome

Counts used to derive rates

Conditions Studied

Study Locations (20)

California

  • University of California - Irvine - Irvine
  • University of California - San Diego - La Jolla
  • University of Southern California - Los Angeles
  • Cedars-Sinai Medical Center - Los Angeles
  • University of California - Los Angeles - Los Angeles
  • Patient-Centered SCAlable National Network for Effectiveness Research - San Diego
  • University of California - San Francisco - San Francisco
  • San Mateo Medical Center - San Mateo

Pennsylvania

  • Penn State College of Medicine - Hershey
  • Temple University - Philadelphia
  • University of Pittsburgh Medical Center - Pittsburgh

Louisiana

  • Research Action for Heath Network - New Orleans
  • University Medical Center - New Orleans

New York

  • New York City Clinical Data Research Network - New York
  • Weill Cornell Medicine - New York

Oregon

  • ADVANCE Clinical Data Research Network - Portland
  • OCHIN, Inc - Portland

Florida

  • Health Choice Network - Miami

Maryland

  • Johns Hopkins University - Baltimore

Massachusetts

  • Fenway Health - Boston

Trial Details

FieldValue
Enrollment Target 15,438,284 participants
Start Date 2018-07-01
Est. Completion 2019-11-15

What the finished NCT03743493 record still lists

NCT03743493 is an observational study that tracks outcomes without assigning an intervention. Its 15,438,284 participants enrollment target places it among the larger protocols in the corpus, above the 1,229-participant average among 105 other Opioid Use trials with a reported enrollment target (1256066% higher).

The record links to 2 conditions, with Opioid Use appearing as the primary indexed condition, and to 0 interventions.

NCT03743493 names 20 study sites across 8 states, led by California, Pennsylvania, Louisiana.

Frequently Asked Questions

What is clinical trial NCT03743493 about?

NCT03743493 is a clinical study titled "PCORnet Opioid Surveillance Study". The overarching objective of this project is to demonstrate and assess the feasibility of using the Patient Centered Outcomes Research Network (PCORnet) Common Data Model for opioid surveillance to complement existing and support future initiatives. This project will characterize risk factors, proce...

What is the current status of trial NCT03743493?

This trial is currently completed. The enrollment target is 15,438,284 participants. The study started on 2018-07-01. Estimated completion is 2019-11-15.

What conditions does trial NCT03743493 study?

This clinical trial studies the following conditions: Opioid Use, Opioid Abuse.

Who is sponsoring clinical trial NCT03743493?

This trial is sponsored by Louisiana Public Health Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03743493 being conducted?

This trial has 20 study locations across California, Florida, Louisiana, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03743493's enrollment target sits among peer trials

15,438,284 1st of 105 higher than 105 of 105 other Opioid Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02485847 · 20,000,000 participants

    IRIS Registry: Intelligent Research in Sight Registry

  • NCT05678699 · 10,000,000 participants · NA

    The Effects of Medicaid Policy Interventions on Racial Equity in Severe Maternal Morbidity

  • NCT02693223 · 3,892,063 participants

    Get With the Guidelines-Stroke Registry

  • NCT06803498 · 3,000,000 participants

    Delivery Room Intervention and Evaluation Network

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03743493, the US trial registry maintained by the National Library of Medicine. NCT03743493 (large enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.